Treatment challenges in and outside a network setting: Gastrointestinal neuroendocrine tumours

被引:12
作者
Laskaratos, Faidon-Marios [1 ]
Caplin, Martyn [1 ]
机构
[1] Royal Free London NHS Fdn Trust, ENETS Ctr Excellence, Ctr Gastroenterol, Neuroendocrine Tumour Unit, London, England
来源
EJSO | 2019年 / 45卷 / 01期
关键词
Gastrointestinal neuroendocrine tumour; Multidisciplinary care; PROGNOSTIC-FACTOR ANALYSIS; MULTIDISCIPLINARY CARE; LIVER METASTASES; RADIONUCLIDE THERAPY; MANAGEMENT; SURVIVAL; BIOMARKERS; EVEROLIMUS; PATHOLOGY; CONSENSUS;
D O I
10.1016/j.ejso.2018.03.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Gastroenteropancreatic neuroendocrine tumours (GEP NETs) are relatively rare neoplasms arising from the enterochromaffin cells of the gastrointestinal tract. They comprise a heterogeneous group of tumours with a diverse natural history, variable biological behaviour and different clinical outcomes. Their management is often complex and may include a combination of surgery, systemic treatments and locoregional approaches. A multidisciplinary team approach is therefore essential for the optimal care of patients with GEP NETs. In this article, the authors review the role and structure of multidisciplinary care models, the importance of regional centres of expertise and institutional networks for the management of these rare neoplasms, as well as the multidisciplinary therapeutic challenges that NET clinicians are often faced with. (C) 2018 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 68 条
[1]   Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund [J].
Aggarwal, A. ;
Fojo, T. ;
Chamberlain, C. ;
Davis, C. ;
Sullivan, R. .
ANNALS OF ONCOLOGY, 2017, 28 (08) :1738-1750
[2]   Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study [J].
Ahmed, A. ;
Turner, G. ;
King, B. ;
Jones, L. ;
Culliford, D. ;
McCance, D. ;
Ardill, J. ;
Johnston, B. T. ;
Poston, G. ;
Rees, M. ;
Buxton-Thomas, M. ;
Caplin, M. ;
Ramage, J. K. .
ENDOCRINE-RELATED CANCER, 2009, 16 (03) :885-894
[3]  
[Anonymous], 2000, NHS CANC PLAN PLAN I
[4]  
[Anonymous], LANCET ONCOL
[5]  
[Anonymous], J GLOBAL ONCOLOGY
[6]  
Banflield A, 2005, HOSP MED, V66, P37
[7]  
Berardi R., 2016, J CANCER METAS TREAT, V2, P277
[8]   Peptide receptor radionuclide therapy (PRRT) for GEP-NETs [J].
Bergsma, Hendrik ;
van Vliet, Esther I. ;
Teunissen, Jaap J. M. ;
Kam, Boen L. R. ;
de Herder, Wouter W. ;
Peeters, Robin P. ;
Krenning, Eric P. ;
Kwekkeboom, Dik J. .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2012, 26 (06) :867-881
[9]   18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors [J].
Binderup, Tina ;
Knigge, Ulrich ;
Loft, Annika ;
Federspiel, Birgitte ;
Kjaer, Andreas .
CLINICAL CANCER RESEARCH, 2010, 16 (03) :978-985
[10]   Pathology: Classification and Immunoprofile [J].
Blank, Annika ;
Schmitt, Anja ;
Perren, Aurel .
NEUROENDOCRINE TUMORS: A MULTIDISCIPLINARY APPROACH, 2015, 44 :104-114